Cooper Companies (COO)

• Market cap: $12.8B
• 1 day: -1.29%
• 5 days: -4.95%
• 1 month: -12.53%
• 3 months: -6.46%
• 6 months: -19.51%
• Year to date: -29.05%
• 1 year: -41.44%
• 5 years: -26.03%
• 10 years: 70.88%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Employees: 16,000

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

345% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $3.47M

2.71% more ownership

Funds ownership: 98.36% [Q1] → 101.07% (+2.71%) [Q2]

1% more repeat investments, than reductions

Existing positions increased: 240 | Existing positions reduced: 238

0% more funds holding in top 10

Funds holding in top 10: 5 [Q1] → 5 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 82

1% less funds holding

Funds holding: 630 [Q1] → 621 (-9) [Q2]

14% less capital invested

Capital invested by funds: $16.6B [Q1] → $14.3B (-$2.29B) [Q2]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $66
• Avg. target: $80
• High target: $94

9 analyst ratings

• positive: 6 67%
• neutral: 3 33%
• negative: 0 0%

JP Morgan Robbie Marcus	$66	Neutral Maintained	28 Aug 2025
Morgan Stanley Patrick Wood	$76	Equal-Weight Maintained	28 Aug 2025
Baird Jeff Johnson	$85	Outperform Maintained	28 Aug 2025
Wells Fargo Larry Biegelsen	$72	Overweight Maintained	28 Aug 2025
Piper Sandler Jason Bednar	$83	Overweight Maintained	28 Aug 2025